2003
DOI: 10.1001/archotol.129.7.733
|View full text |Cite
|
Sign up to set email alerts
|

Voice and Swallowing in Patients Enrolled in a Larynx Preservation Trial

Abstract: Laryngeal preservation resulted in voice and swallowing abnormalities, but they tend to be mild to moderate, allowing intelligible communication and efficient swallowing in most patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
51
1
3

Year Published

2006
2006
2013
2013

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(57 citation statements)
references
References 21 publications
2
51
1
3
Order By: Relevance
“…Swallowing dysfunction has been correlated with dose and volume parameters of the upper aerodigestive tract (14)(15)(16). Organ preservation treatment impairs movement of structures that are essential for effective swallowing (17)(18)(19).…”
Section: Discussionmentioning
confidence: 99%
“…Swallowing dysfunction has been correlated with dose and volume parameters of the upper aerodigestive tract (14)(15)(16). Organ preservation treatment impairs movement of structures that are essential for effective swallowing (17)(18)(19).…”
Section: Discussionmentioning
confidence: 99%
“…Common treatment sequelae included prolonged tube feedings, recurrent aspiration pneumonia, and radiation-induced oropharyngeal stricture. In one study, the rate of silent aspiration was 36% (5/14) following chemoradiation for larynx preservation [16] . The limitations of these studies were the small number of patients and the short follow-up.…”
Section: Discussionmentioning
confidence: 99%
“…7,8 A close match is the study by Carrara-de Angelis et al, 15 in which three trained listeners prospectively analyzed voice quality of 43 patients with hypopharyngeal and laryngeal cancer treated with CCRT using the GRBAS scale. Normal voice was perceived in one (7%) of the 15 patients, mild dysphonia in four (27%), moderate in six (40%), and severe in four (27%) at 2-9 months after CCRT.…”
Section: E30mentioning
confidence: 98%